Memotext

memotext-solid- resizable (1)

Media

From the MedX Mainstage to the TSX (Toronto Stock Exchange)

Looking back on MEMOTEXT’s accomplishments this fall

Posted on December 2, 2015 by Noah Nemoy

This autumn has been an exciting time for MEMOTEXT. In September our Founder and President Amos Adler had the opportunity to be a main stage speaker at Stanford Medicine X 2015. Presenting the abstract: “Using Disparate Data to Personalize Digital Health Behavior Change Interventions” Amos rocked the crowd explaining the MEMOTEXT methodology. He had a fantastic time at the event and the “Cat pics + health data = behavior change” line got a substantial amount of press coverage.

Read More »
1 December 2015

Click Bait for Your Health: How a Toronto Startup Uses Digital Engagement to Increase Medication Adherence

Posted on November 20, 2015 by Amos Adler

Using digital engagement to increase medication adherence is our novel solution to a complex problem. With non-adherence caused by multiple factors unique to each individual patient, a-one-size-fits-all-solution can’t work and won’t work. Instead, at MEMOTEXT we personalize each patient’s support program. By encouraging patient input, adapting to changes in mood and lifestyle, we can develop a medication adherence and support program that works best.

Read More »
25 November 2015

If I had $290 billion: Breaking Down the Cost of Medication Compliance

Posted on November 05, 2015 by Noah Nemoy

Medication Compliance is one of the biggest costs to worldwide healthcare systems. 50% of all patients do not take their medication as prescribed and this costs the U.S. healthcare system alone $290 billion per year. That’s a pretty massive figure that can be interpreted in several ways.

We can start by breaking down that $290 billion to show exactly how low compliance rates create such a huge cost:

Read More »
5 November 2015

EmpathyX – My MedXHangover Elixer

Posted on October 02, 2015 by Amos Adler

Keywords: #MedXHangover #EmpathyX #MedXorcism, #ActionX

So I’m currently suffering from what’s known as #MedXHangover. Its real, I assure you. Fortunately I don’t have #SyndromeX, a condition associated with attending uncomfortable doctor-patient simulations to simulate uncomfortable doctor-patient interactions.

Read More »
1 October 2015

MEMOTEXT Goes to the Canadian Psychiatric Association (CPA) Annual meeting in Vancouver, BC.

Posted on September 30, 2015 by Bill Simpson

As the Director of Scientific Development for MEMOTEXT I am honoured to have been invited to speak at this year’s Canadian Psychiatric Association (CPA) annual conference. The 2015 conference runs from Annual Conference October 1st – 3rd in Vancouver, British Columbia. I will be speaking at the “A clinician’s guide to mental health apps.” symposium on Thursday, October 1st at 10:15 PST. The focus of my contribution will be on mHealth and its capacity to affect positive behavioural change.

Read More »
30 September 2015

MEMOTEXT Founder and President Amos Adler to Present at Stanford Medicine X 2015

Abstract: “Using Disparate Data to Personalize Digital Health Behavior Change Interventions” to be presented at conference main stage

Toronto, ON September 16, 2015 – MEMOTEXT is pleased to announce that our Founder and President Amos Adler will be a main stage speaker at Stanford Medicine X 2015. Running from September 23-27 in the heart of Silicon Valley, Medicine X is a catalyst for sharing new ideas on the intersection of healthcare and emerging technologies. Hosted by Stanford University, Medicine X brings together both business and academia for a 4 day conversation on the future of healthcare.

Read More »
16 September 2015

The Meaning of “Meaningful Use”

How MEMOTEXT helps you achieve it

Posted on October 13, 2015 by Noah Nemoy

If you’re an American health care provider or are involved in digital health, odds are you’ve been hearing a lot about Meaningful Use (MU) Stage 3 in recent years. But what is it exactly? Why does it matter? And while we’re at it, what is MU Stages 1 and 2?

Read More »
1 September 2015

MEMOTEXT Publishes Whitepaper on Patient Adherence & Digital Health Interventions

“The MEMOTEXT Toolkit” walks readers through the problem of patient non-adherence, explaining the methodology behind our digital health interventions

Posted on July 23, 2015 by Noah Nemoy

MEMOTEXT is pleased to unveil “The MEMOTEXT Toolkit” Whitepaper. Authored by MEMOTEXT’s President and Founder Amos Adler M.Sc., Director of Scientific Development Bill Simpson P.hD(c) and Miki Peer P.hD(c), the document explains both the problem of patient adherence and outlines the science behind MEMOTEXT’s methodology.

Read More »
22 July 2015

We’re Going to Stanford!

MEMOTEXT Founder and President Amos Adler to Present at Stanford Medicine X 2015

Posted on July 23, 2015 by Noah Nemoy

MEMOTEXT is pleased to announce that our President and Founder Amos Adler will be speaking at Stanford Medicine X 2015! Running from September 23-27 in the heart of Silicon Valley, Medicine X is a catalyst for sharing new ideas on the intersection of healthcare and emerging technologies. Hosted by Stanford University, Medicine X brings together both business and academia for a 4 day conversation on the future of healthcare.

Read More »
22 July 2015

MEMOTEXT Makes the Top 20

MEMOTEXT is named by HIT Consultant as one of the Top 20 Canadian Digital Health Technology Start-Ups to Watch

Posted on July 23, 2015 by Noah Nemoy

Earlier this month HIT Consultant, released their list of the Top 20 Canadian digital health companies to lookout for. The companies on the list were selected for their potential for growth and represented disparate areas of digital health, including digital health solutions, diagnostics, and patient centred care. MEMOTEXT managed to not only make the Top 20, but was also one of the Top 10 digital health start-ups in Eastern Canada, and the only company of the 20 with an exclusive focus on patient adherence.

Read More »
22 July 2015

MEMOTEXT Pitches PAAS2015

Posted on July 6, 2015 by Noah Nemoy

Last week, MEMOTEXT Founder and President Amos Adler was invited to both attend and present at the 14th Annual Patient Adherence & Access Summit, or PAAS2015 in Philadelphia. While there MEMOTEXT had the opportunity to share in the discussion of the latest issues regarding patient adherence and access, to medication.

Read More »
6 July 2015

MEMOTEXT Presents at the Pittsburgh Science of Medication Adherence:

Director of Scientific Development Bill Simpson unveils our new BAM adherence metric

Posted on June 26, 2015 by Bill Simpson

2 weeks ago MEMOTEXT had the privilege of presenting our new Balanced Adherence Metric (BAM) at the inaugural Science of Medication Adherence Conference (SMA2015), hosted by the University of Pittsburgh Centre for Pharmaceutical Policy and Prescribing.

Read More »
26 June 2015

We use cookies to ensure you get the best experience on our website. By continuing to browse this website, you accept the use of the cookies for the stated purpose. Learn more by reading our privacy policy.

Got It

Join the MEMOTEXT Mailing List!

Get updates on new products, projects and stay on top of all things MEMOTEXT.